EHC - Company ID 0000785161
The table below shows Encompass Health Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $236.20M |
Encompass Health Corp reported annual revenue of $5.94B for fiscal year 2025. That is up 10.5% from $5.37B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $3.64B (FY 2016) to $5.94B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $209.20M |
| $201.70M |
| $154.30M |
| $169.50M |
| $151.60M |
| Operating income | - | - | - | $539.50M | $559.60M | $563.90M |
| Income tax | $192.90M | $150.20M | $132.20M | $100.10M | $101.90M | $74.70M |
| Net income | $566.20M | $455.70M | $352.00M | $271.00M | $412.20M | $284.20M |
| EPS (diluted) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 |